Koyfin Home > Directory > Health Care > Biogen Inc > Long-Term Debt

Biogen Inc Long-Term Debt Chart (BIIB)

Biogen Inc annual/quarterly Long-Term Debt from 2010 to 2020.
  • Biogen Inc Long-Term Debt for the quarter ending September 09, 2020 was $7,425m a 39.95% increase of 2,966m year over year
  • Biogen Inc Long-Term Debt for the last 12 months ending September 09, 2020 was $7,425m a 39.95% increase of 2,966m year over year
  • Biogen Inc Annual Long-Term Debt for 2019 was $4,459m a -33.14% decrease of -1,478m from 2018
  • Biogen Inc Annual Long-Term Debt for 2018 was $5,937m a 0.03% increase of 2m from 2017
  • Biogen Inc Annual Long-Term Debt for 2017 was $5,935m a -9.73% decrease of -578m from 2016
Other Cash Flow Metrics:
  • Biogen Inc Cash Flow from Operations for the quarter ending September 09, 2018 was $1,736m a 12.54% increase of 218m year over year
  • Biogen Inc Levered Free Cash Flow (FCF) for the quarter ending September 09, 2018 was $1,098m a 0.14% increase of 2m year over year
  • Biogen Inc Total Revenue for the quarter ending December 12, 2018 was $3,526m a 11.21% increase of 395m year over year
View Chart On Koyfin

Quarterly BIIB Long-Term Debt Data

09/2020$7,425m
06/2020$7,424m
03/2020$4,460m
12/2019$4,459m
09/2019$4,458m
06/2019$5,949m
03/2019$5,943m
12/2018$5,937m
09/2018$5,931m
06/2018$5,928m

Annual BIIB Long-Term Debt Data

2019$4,459m
2018$5,937m
2017$5,935m
2016$6,513m
2015$6,522m
2014$580m
2013$592m
2012$687m
2011$1,061m
2010$1,066m